Inventor

JOENS OLAF

DE9 patents

⚠️ This page may combine multiple inventors who share the name “JOENS OLAF”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

DAEMMGEN JUERGEN

5 patents

US8980894B2Mar 17, 2015

Use of PDE III inhibitors for the treatment of asymptomatic (occult) heart failure

DAEMMGEN JUERGEN16 citations88

US9889148B2Feb 13, 2018

Use of pimobendan for the reduction of heart size in mammals suffering from heart failure

DAEMMGEN JUERGEN7 citations81

US9463199B2Oct 11, 2016

Use of PDE III inhibitors for the reduction of heart size in mammals suffering from heart failure

DAEMMGEN JUERGEN3 citations70

US10117869B2Nov 6, 2018

PDE III inhibitors for treatment of asymptomatic heart failure

DAEMMGEN JUERGEN4 citations68

US8664252B2Mar 4, 2014

Phosphodiesterase type III (PDE III) inhibitors or CA2+-sensitizing agents for the treatment of hypertrophic cardiomyopathy

DAEMMGEN JUERGEN0 citations49

BOEHRINGER INGELHEIM VETMEDICA GMBH

4 patents

US10537588B2Jan 21, 2020

Use of pimobendan for the reduction of heart size in mammals suffering from heart failure

BOEHRINGER INGELHEIM VETMEDICA GMBH6 citations82

US10537570B2Jan 21, 2020

Use of pimobendan for the reduction of heart size and/or the delay of onset of clinical symptoms in patients with asymptomatic heart failure due to mitral valve disease

BOEHRINGER INGELHEIM VETMEDICA GMBH4 citations64

US11413285B2Aug 16, 2022

PDE III inhibitors for treatment of asymptomatic heart failure

BOEHRINGER INGELHEIM VETMEDICA GMBH0 citations58

US12011441B2Jun 18, 2024

Pimobendan for the reduction of heart size and/or the delay of onset of clinical symptoms in patients with asymptomatic heart failure due to mitral valve disease

BOEHRINGER INGELHEIM VETMEDICA GMBH0 citations52